Late Phase Clinical Trials
Late phase clinical trials are all about a successful transition from development to commercialisation and it is important to understand that they are conducted for various reasons that differ to those of earlier stage clinical trials. In some cases, it will be for providing a strong confirmation of your product’s pre-approval study data on larger patient groups; in other case, it will be for the exploration of new indications by studying different patient populations.
Different goals mean a different approach and we always keep in mind that your clients are our clients too. In this context, we will strive to develop a fruitful relationship with investigators and to promote the image of your company and compounds as if they were our own. We know you worked hard to build and maintain sponsor/site relationships and we will make sure we never compromise them. Our monitors will simply be an extension of your own field staff.
At every stage of the project we will give you the visibility and transparency you need to check the progress of your research without involving you in tedious micromanagement and unnecessary work.
Project Management / Medical Writing / Medical Monitoring
Site Identification and Qualification / Regulatory Affairs
Clinical Monitoring / Data Management and Biostatistics
Pharmacovigilance / Quality Assurance
Call us to find out how our Phase II and III Clinical Trials Solutions can work for you
Health News - Africa
- Nigeria:Culture, Religious Misconceptions Hindering Family Planning in Nigeria
- Malawi:Muluzi Hails UK for Funding Sexual Health Services in Malawi - K47.bn 'Tsogolo Langa' Programme
- Tanzania:Dar Picked Host for Haematology Expertise Centre
- Angola:Health Professionals Call for Improvement of Road Access to Hospitals
- Ghana:First Survey to Determine the Cost for the Treatment of Tuberculosis Launched
- Congo-Kinshasa:Armed Groups Hamper Fight Against Ebola
- Uganda:Joint Effort to Eliminate River Blindness Bearing Fruit for Uganda
- Africa:Let Food Be Thy Medicine
- South Africa:Bureaucracy, Power and Grants - When a Pen May Be As Mighty As the Scalpel
- Africa:Almost Half of Injecting Drug Users Could Be Living With Hepatitis C